<?xml version="1.0" encoding="UTF-8"?>
<p id="p0015">Based on information from the pandemic in China and European countries, the WHO alerted that pre-existing non-communicable diseases (NCD) and modifiable risk factors such as smoking and obesity increase the vulnerability of patients with COVID-19 to becoming severely ill, increasing the risk of hospitalization and death (
 <xref rid="bib3" ref-type="bibr">3</xref>). A meta-analysis of confirmed COVID-19 cases from China placed hypertension, diabetes, cardiovascular disease and respiratory system disease as the most prevalent underlying NCDs, in that order (
 <xref rid="bib4" ref-type="bibr">4</xref>). Among hospitalized patients in Wuhan, China 64% had at least one comorbidity, with hypertension the most common, while 72.2% of patients with any NCD required intensive healthcare as against 37.3% among those without NCDs (
 <xref rid="bib5" ref-type="bibr">5</xref>). A meta-analysis or publications across various countries established that chronic kidney disease trebles the risk of severe COVID-19 infection (
 <xref rid="bib6" ref-type="bibr">6</xref>). The increased risk of NCD on COVID-19 severity has also been shown for the United States (
 <xref rid="bib7" ref-type="bibr">7</xref>,
 <xref rid="bib8" ref-type="bibr">8</xref>). Hospitalized patients in New York were reported with high NCD prevalence rates, with up to 56.6% reporting hypertension, 33.8% diabetes and 41.7% obesity (
 <xref rid="bib9" ref-type="bibr">9</xref>).
</p>
